Symbol | Exchange | Currency |
|---|
Seven days ago, Bitcoin.com News reported on the Tron DAO Reserve purchasing $38 million in tron to safeguard the network’s stablecoin USDD. Since then and since the terrausd (UST)...
On May 5, Tron’s algorithmic stablecoin USDD went live and so far, the fiat-pegged token has been listed on a number of decentralized finance (defi) protocols. Two days later, the...
TRX was up by over 17% on Thursday, as founder H.E. Justin Sun announced that a new stablecoin, USDD, was going to be launched on the TRON blockchain. XMR was another big mover...
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, and GBM-V & Cardiac divisions. The company provides dCELL technology, a soft tissue decellularisation process that removes DNA and cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductive to stimulate and regenerate native bone growth. In addition, the company provides DermaPure, a decellularised dermal allograft for reinforcement, repair, and replacement of damaged or inadequate integumental tissue and other homologous uses of human integument; and SurgiPure XD, Decellularised porcine dermal reconstructive tissue matrix for the repair of hernias and body wall defects. Further, it offers OrthoPure XT, a scaffold to replace the damaged tissue that will re-populate with the patient’s own cells; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft, which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Additionally, the company provides DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; CardioPure products; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks for ophthalmology and wound covering; and sports medicine products. The company was incorporated in 2006 and is based in Garforth, the United Kingdom.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Sell | Buy | Buy | Strong Sell | Strong Sell |
| Summary | Strong Sell | Neutral | Neutral | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 158.50 | 158.50 | 154.50 | +4.00 | +2.59% | 66.28K | London | |||
| 600.00 | 603.00 | 599.00 | +6.00 | +1.01% | 49.84K | London | |||
| 110.00 | 110.00 | 110.00 | +5.00 | +4.76% | 39.63K | London | |||
| 0.0225 | 0.0225 | 0.0225 | 0.0000 | 0.00% | 0.00 | London | |||
| 669.20 | 710.20 | 668.40 | -8.80 | -1.30% | 269.30K | London | |||
| 754.80 | 775.80 | 738.20 | +11.80 | +1.59% | 1.33M | London | |||
| 78.90 | 81.55 | 78.90 | -0.70 | -0.88% | 2.96M | London | |||
| 0.62 | 0.61 | 0.61 | +0.01 | +2.05% | 121.72K | London | |||
| 157.50 | 157.50 | 157.50 | +5.00 | +3.28% | 61.19K | London | |||
| 5.49 | 5.50 | 5.49 | 0.00 | 0.00% | 0.00 | London | |||
| 2,195.00 | 2,270.00 | 2,180.00 | -30.0 | -1.35% | 120.45K | London | |||
| 1,006.00 | 1,044.00 | 994.40 | +28.80 | +2.95% | 7.33M | London | |||
| 626.20 | 641.00 | 624.60 | +5.80 | +0.94% | 1.33M | London | |||
| 28.55 | 30.40 | 28.00 | -0.45 | -1.55% | 5.36M | London | |||
| 210.30 | 213.00 | 209.50 | +1.20 | +0.57% | 13.57M | London |